NL-OMON30381招募中不适用
T and NK cell mediated immunotherapy in osteosarcoma; a preclinical feasibility study - T and NK cell mediated immunotherapy in osteosarcoma
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 2 至 99（—）
入选标准
- •All newly diagnosed osteosarcoma patients in the LUMC
- •Written informed consent
排除标准
- •Lack of written informed consent
研究者
相似试验
尚未招募
不适用
T and NK cell mediated immunotherapy in Ewing's sarcoma (P03.040 amended version of December 2006)bone tumors10040778NL-OMON31114Academisch Medisch Centrum25
招募中
不适用
Development of novel immunotherapy using NKT cells for malignant solid tumors in childreHealthy volunteersJPRN-UMIN000048076Chiba University30
未知
1 期
Immunotherapy with NK cellsClinical study to investigate safety and efficacy on NK cells to health and cancerJPRN-UMIN000002134Kuramae clinic15
已完成
2 期
Natural Killer (NK) Cell Adback After Allogeneic Stem Cell Transplant With Campath-IH Plus Chemorx for Patients With Lymphoid MalignanciesLymphomaLeukemiaNCT00536978M.D. Anderson Cancer Center22
已完成
2 期
Targeted Natural Killer (NK) Cell Based Adoptive Immunotherapy for the Treatment of Patients With Non-Small Cell Lung Cancer (NSCLC) After Radiochemotherapy (RCT)NSCLC Stage IIIA/BNCT02118415Technical University of Munich13